Skip to content
Search

Latest Stories

33 % rise in women seeking perinatal mental health support since 2022

33 % rise in women seeking perinatal mental health support since 2022
One in five new and expectant mothers may be affected by perinatal mental health conditions

In a significant uptick reflecting growing awareness and acceptance of mental health challenges among new and expectant mothers, NHS records reveal a striking surge in specialist support sought by over 57,000 new mothers over the past year.

This figure represents a substantial 33 per cent increase compared to the 2022 data findings indicating a heightened demand for perinatal mental health services in England.


Last year, the number of women accessing perinatal mental health services was 43,053 individuals.

Specifically, between March 2023 and February 2024, a total of 57,170 women accessed these services, representing a significant rise from the 43,053 women who received support between March 2022 and February 2023.

Contextually, this surge in demand is significant given that approximately 600,000 women give birth in England each year.

Research underscores the prevalence of perinatal mental illness, affecting up to one in five new and expectant mothers, and spanning a diverse range of conditions.

Under the NHS Long Term Plan, the government has made provisions of specialist mental health teams in every part of England facilitating access to crucial support services for women experiencing moderate to severe or complex mental health needs during pregnancy and childbirth. 

Part of the care and support provided to new mums is the NHS mental health support team offers comprehensive assistance, including guidance on nurturing the parent-child relationship.

Additionally, a thorough mental and physical health check-up within six weeks of giving birth is also part of the support, ensuring that potential mental health concerns are identified and addressed early on.

The health agency warns that if left untreated, these issues can have lasting repercussions for both the mother and child, underlining the significance of timely intervention and support.

Encouraging women to seek support, Claire Murdoch, NHS England’s National Mental Health Director, emphasised the importance of early intervention in addressing mental health difficulties during the perinatal period.

"Becoming a new mum is an incredibly special moment, but it can also be a very stressful and overwhelming experience", she said.

"The NHS wants to make sure that those suffering with any mental health difficulty such as post-traumatic stress or severe depression get the support they need."

She highlighted the expertise of specialist teams across the country, urging pregnant women and new mothers to reach out for assistance without hesitation.

Additional investments are being channelled into service developments, with a focus on improving access to evidence-based therapies and bolstering community care for women up to 24 months after giving birth.

More For You

Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less